CLTR COULTER PHARMACEUTICAL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob L who wrote (386)	11/21/1999 5:56:00 PM
From: WTDEC	Read Replies (2) of 666

Bob, Well I think all of us 'beat this horse to death', so I offer no further arguments. Nevertheless, I can't resist pointing out what Avalon now thinks about Zev <G>...maybe they will go long on CLTR <GG> "Oh, oh. Avalon is headed your way. Forbes article: "But the stock is overvalued, say analysts at Avalon Research Group. . . . And Idec's next drug in the pipeline has limited potential. Scheduled for mid-2001, Zevalin is a last-resort therapy for non-Hodgkins lymphoma patients and has severe side effects." forbes.com My hope and prayers are that we will get to 100% CRs...maybe some combo of Rit and Bex will get us there... Best regards, Walter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next